MetLife Investment Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
2020
Q1
$89.4K Hold
2019
Q4
$196K Hold
2019
Q3
$192K Hold
2019
Q2
$283K Hold
2019
Q1
$237K Buy
2018
Q4
$113K Hold
2018
Q3
$198K Hold
2018
Q2
$192K Hold
2018
Q1
$183K Hold
2017
Q4
$186K Buy